Select Medical Holdings (SEM) Appoints Parvinderjit Singh Khanuja to its Board
Get Alerts SEM Hot Sheet
Join SI Premium – FREE
Select Medical Holdings Corporation (NYSE: SEM) today announced the appointment of Parvinderjit Singh Khanuja, M.D. to its Board of Directors (the "Board"), effective on November 1, 2021. Dr. Khanuja's Board term will expire at Select Medical's 2023 Annual Meeting of Stockholders, at which time he will stand for election along with the other director nominees standing for election at that meeting.
"We are very pleased to welcome Dr. Khanuja to the Select Medical Board of Directors," said Robert A. Ortenzio, Executive Chairman and Co-Founder of Select Medical. "Dr. Khanuja brings to Select Medical over three decades of experience in the practice of medical oncology and as a business leader. He will share an important perspective and will be a valued addition to the Board."
Dr. Khanuja joins the Board with over 30 years of experience as a medical oncologist. Dr. Khanuja is the founder and Managing Partner of Ironwood Physicians, PC, the largest cancer treatment center in the Phoenix, AZ metropolitan area with over 100 providers. Dr. Khanuja is a Diplomate, Subspecialty Board of Medical Oncology and Hematology and is a Fellow of the American College of Physicians (FACP). Dr. Khanuja is a board member of the Five Rivers Foundation, which is primarily involved in social causes and scholarships. He is also a member of the Board of Trustees of the Phoenix Art Museum.
Dr. Khanuja completed his medical degree at Christian Medical College in Ludhiana, India. His fellowship followed at Wayne State University School of Medicine in Detroit.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rapid Line sees stock surge with no known corporate cause
- Robert Beck joins Encore Capital Group board of directors
- ONE Nuclear Energy names CFO and nominates new board director
Create E-mail Alert Related Categories
Board Changes, Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share